Profiles, co-morbidity and their relationship to treatment of 191 children with AD/HD and their families

Eur Child Adolesc Psychiatry. 2004 Aug;13(4):234-42. doi: 10.1007/s00787-004-0380-4.

Abstract

Background: This study was set up to re-audit our use of a protocol for the assessment and treatment for children on psycho-stimulant medication within a community clinic for children with Attention Deficit/Hyperactive Disorder (AD/HD) and to examine the profile of children and their families referred to the clinic in order to consider their assessment and treatment needs.

Method: A questionnaire based on results from previous studies was completed for 191 patients from a case note audit, and by questioning clinicians. Key areas examined were symptomatology and child and family variables, which included learning difficulties, medical problems, psychosocial factors and side-effects of medication.

Results: The protocol was used appropriately with the majority of children. Children with AD/HD referred to the clinic often presented with co-morbid psychopathology, e. g. conduct disorder, low self-esteem, and frequently experienced family and psychosocial difficulties.

Conclusions: Protocols in clinics are useful as this should maintain good practice and allow on-going monitoring, but they need precise use. Also, as many children with AD/HD present with co-morbid psychopathology and complicated family dynamics to Child and Adolescent Mental Health Services, this will influence assessment and treatment needs and require increased resources.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / diagnosis
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / epidemiology*
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Comorbidity
  • Family / psychology*
  • Female
  • Health Status*
  • Humans
  • International Classification of Diseases
  • Learning Disabilities / epidemiology*
  • Male
  • Methylphenidate / administration & dosage
  • Methylphenidate / therapeutic use*
  • Severity of Illness Index
  • Surveys and Questionnaires

Substances

  • Central Nervous System Stimulants
  • Methylphenidate